​

Funding Round

Series B - Oculex Pharmaceuticals

Series B - Oculex Pharmaceuticals

Investment Firm

Overview

Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.

Announced Date

Oct 22, 2002

Funding Type

Series B

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Bay City Capital

Bay City Capital

Bay City Capital is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

6

Investor Name
Participant InvestorNotable Capital
Participant InvestorBay City Capital
Participant InvestorAisling Capital
Participant InvestorVenture TDF
Participant InvestorVivo Capital

Round Details and Background

Oculex Pharmaceuticals raised $50000000 on 2002-10-22 in Series B

Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 22, 2002
Series B - Oculex Pharmaceuticals
6-50.0M

Recent Activity

There is no recent news or activity for this profile.